Abnormalities in glutamate metabolism and glutamatergic neurotransmission a
ppear to play an important role in the pathogenesis of hyperammonemia and h
epatic encephalopathy. Previous studies from our laboratory have shown that
treatment of cultured astrocytes with NH4Cl result in decreased glutamate
uptake. To extend these observations, we performed a Northern blot analysis
of the astroglial glutamate transporter GLAST (EAAT1) in NH4Cl-treated pri
mary rat astrocyte cultures. Following treatment with 2, 5, 10 mM NH4Cl for
3 days, cortical astrocytes showed a 22, 29, 36% decrease: in GLAST mRNA,
respectively. Striatal astrocytes showed 25, 51, 50% reduction, while cereb
ellar cultures showed decrements of 18, 37, 38%. Similar decreases in GLAST
mRNA were also observed after 1 day of ammonia treatment. These findings,
together with recent reports on the reduction of the GLT-1 glutamate transp
orter in in vivo models of acute liver failure and hyperammonemia, strongly
suggest that an abnormality in astroglial glutamate uptake constitutes a c
ritical aspect in the pathogenesis of hepatic encephalopathy and other hype
rammonemic conditions. (C) 1999 Published by Elsevier Science Ireland Ltd.
All rights reserved.